久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

GSK probe shows tightened drug sector supervision

Xinhua | Updated: 2013-07-19 10:29

BEIJING - An ongoing probe into suspected economic violations by multinational drugmaker GlaxoSmithKline (GSK) employees is being seen as part of efforts to tighten supervision in the medical sector.

The Ministry of Public Security announced last week that some employees from GSK China are being investigated for suspected bribery and tax-related violations. Four senior executives from the company are being held by police over their alleged involvement.

The probe has shed light on instances of hidden bribery that have driven up medicine prices. However, the case is not the first of its kind to be uncovered in China.

In December last year, the US Securities and Exchange Commission (SEC) charged Eli Lilly and Company for its involvement in instances of alleged bribery that occurred in several countries, including China.

Four months before the Eli Lilly case, Pfizer's subsidiary in China was also found to have been involved in bribery.

The GSK suspects are believed to have several methods of concealment, such as channelling bribes through travel agencies.

It is believed that the exposure of the bribery represents just the tip of the iceberg.

An anonymous medical salesman from North China's Tianjin municipality said salesmen have had to come up with more creative ways to bribe doctors and convince them to raise the cost of their medicine.

"In most cases, the doctors don't extort money in such explicit terms, but it is certain that they will not order products from those who do not give them a 'good return'," he said.

The unfair market advantage that enterprises have gained by using bribery may make it harder for smaller companies to survive and develop. In addition, the costs of bribery are eventually transferred to patients.

According to suspect Liang Hong, a medication that costs only 30 yuan to produce could end up setting patients back 300 yuan due to bribery.

Bribery can also affect patients' health, as bribes may influence doctors' decisions regarding what medication to prescribe.

A commerce official said Wednesday that the GSK probe is part of efforts to improve China's business climate and create equal competition opportunities for domestic and overseas investors.

The official said China firmly opposes any form of commercial bribery, and all companies, Chinese and foreign alike, will be subject to legal sanctions and assume legal responsibility if they break Chinese law.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 在线视频一区二区三区三区不卡 | 九九99久麻豆精品视传媒 | 久久久久在线 | a大片久久爱一级 | 碰超在线观看 | 久久久综合视频 | 99久久免费国产香蕉麻豆 | 久久永久免费 | 久久精品成人国产午夜 | 中国三级毛片 | 九九九九九九精品免费 | 欧美一级片在线视频 | 久久在线影院 | 看色网站 | 国产成人综合亚洲 | 成人精品一区二区三区 | 成年美女黄网站小视频 | 色狠狠色综合吹潮 | 久久综合九色综合欧洲色 | 国产网曝手机视频在线观看 | 最新欧美一级视频 | 日本一级在线播放线观看视频 | 久久综合久久自在自线精品自 | 美国三级网| 国产成人久久777777 | 欧美成人精品第一区 | 福利片成人午夜在线 | 欧美黄色xxx| a级片在线免费看 | 日韩特黄毛片 | 久久精品精品 | 日本久久久久久 | 日韩欧美a级高清毛片 | 国产三级毛片视频 | 亚洲高清自拍 | 日韩免费黄色片 | 尤蜜网站在线进入免费 | 成人性欧美丨区二区三区 | 亚洲欧美国产中文 | 中文字幕有码在线 | 欧美亚洲精品在线 |